IGC Pharma 주식 주식분석 | 주식가격 | 뉴스 | IGC | US45408X3089 | A1T87A

날짜	IGC Pharma 주식 가격
	0.39 undefined
	0.43 undefined
	0.35 undefined
	0.35 undefined
	0.34 undefined
	0.34 undefined
	0.34 undefined
	0.35 undefined
	0.35 undefined
	0.34 undefined
	0.35 undefined
	0.35 undefined
	0.36 undefined
	0.36 undefined
	0.37 undefined
	0.37 undefined
	0.37 undefined
	0.35 undefined
	0.35 undefined
	0.35 undefined
	0.35 undefined

날짜	IGC Pharma 매출	IGC Pharma EBIT	IGC Pharma 이익
2027e	1.52 백만 undefined	-12.8 백만 undefined	-6.7 백만 undefined
2026e	1.3 백만 undefined	-10.61 백만 undefined	-7.55 백만 undefined
2025e	1.14 백만 undefined	-9.86 백만 undefined	-7.93 백만 undefined
2024	1.35 백만 undefined	-8.8 백만 undefined	-13 백만 undefined
2023	910,000 undefined	-11.19 백만 undefined	-11.51 백만 undefined
2022	400,000 undefined	-10.68 백만 undefined	-15.02 백만 undefined
2021	900,000 undefined	-8.72 백만 undefined	-8.81 백만 undefined
2020	4.07 백만 undefined	-6.87 백만 undefined	-7.32 백만 undefined
2019	5.12 백만 undefined	-4.64 백만 undefined	-4.1 백만 undefined
2018	2.19 백만 undefined	-1.79 백만 undefined	-1.79 백만 undefined
2017	580,000 undefined	-2.05 백만 undefined	-1.87 백만 undefined
2016	6.37 백만 undefined	-2.59 백만 undefined	-2.81 백만 undefined
2015	7.68 백만 undefined	-4.34 백만 undefined	-4.61 백만 undefined
2014	2.27 백만 undefined	-2.51 백만 undefined	-3.02 백만 undefined
2013	8.03 백만 undefined	-2.18 백만 undefined	-2.25 백만 undefined
2012	4.2 백만 undefined	-6.32 백만 undefined	-7.75 백만 undefined
2011	4.07 백만 undefined	-7.91 백만 undefined	-20.24 백만 undefined
2010	17.9 백만 undefined	-3.99 백만 undefined	-4.79 백만 undefined
2009	35.34 백만 undefined	2.31 백만 undefined	-520,000 undefined
2008	2.19 백만 undefined	-20,000 undefined	-5.22 백만 undefined
2007	0 undefined	0 undefined	1.52 백만 undefined
2006	0 undefined	-530,000 undefined	-440,000 undefined

	매출	EBIT	이익
2006	0 USD	-530,000 USD	-440,000 USD
2007	0 USD	0 USD	1.52 백만 USD
2008	2.19 백만 USD	-20,000 USD	-5.22 백만 USD
2009	35.34 백만 USD	2.31 백만 USD	-520,000 USD
2010	17.9 백만 USD	-3.99 백만 USD	-4.79 백만 USD
2011	4.07 백만 USD	-7.91 백만 USD	-20.24 백만 USD
2012	4.2 백만 USD	-6.32 백만 USD	-7.75 백만 USD
2013	8.03 백만 USD	-2.18 백만 USD	-2.25 백만 USD
2014	2.27 백만 USD	-2.51 백만 USD	-3.02 백만 USD
2015	7.68 백만 USD	-4.34 백만 USD	-4.61 백만 USD
2016	6.37 백만 USD	-2.59 백만 USD	-2.81 백만 USD
2017	580,000 USD	-2.05 백만 USD	-1.87 백만 USD
2018	2.19 백만 USD	-1.79 백만 USD	-1.79 백만 USD
2019	5.12 백만 USD	-4.64 백만 USD	-4.1 백만 USD
2020	4.07 백만 USD	-6.87 백만 USD	-7.32 백만 USD
2021	900,000 USD	-8.72 백만 USD	-8.81 백만 USD
2022	400,000 USD	-10.68 백만 USD	-15.02 백만 USD
2023	910,000 USD	-11.19 백만 USD	-11.51 백만 USD
2024	1.35 백만 USD	-8.8 백만 USD	-13 백만 USD
2025e	1.14 백만 USD	-9.86 백만 USD	-7.93 백만 USD
2026e	1.3 백만 USD	-10.61 백만 USD	-7.55 백만 USD
2027e	1.52 백만 USD	-12.8 백만 USD	-6.7 백만 USD

2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024

65.83	70.27	11.4	2.13	0.84	1.58	0.56	1.06	1.03	0.82	1.49	2.42	1.66	25.61	12.34	14.63	10.46	3.35	1.2
0	0	15.29	12.36	7.9	3.31	1.64	1.07	0.57	0.99	0.96	0.75	0.56	0.08	0.13	0.18	0.13	0.11	0.04
0	0.04	0.28	0	0	0	0	0	0	0	0	0	0	0	0	1.74	0.47	0.02	0.05
0	0	1.55	2.12	0.16	0.13	0.39	0.41	0.61	0.71	0.16	0	0.49	0.25	4.25	5.48	3.55	2.65	1.54
0.08	0.07	4.38	2.89	2.2	1.52	2.63	1.73	1.56	1.95	1.23	0.41	0.5	0.78	1.04	1.5	0.51	0.33	0.88
65.91	70.38	32.9	19.5	11.1	6.54	5.22	4.27	3.77	4.47	3.84	3.58	3.21	26.72	17.76	23.53	15.12	6.46	3.7
0	0	7.34	6.6	1.75	1.23	8.49	8.18	7.59	7.78	7.07	0.95	6.24	5.89	10.35	11.33	9.87	8.54	3.89
0	0	1.69	0.07	9.25	7.31	5.75	5.19	5.14	6.03	5.78	6.01	0.8	0.79	0.01	0.01	0	0	0
0	0	3.52	2.77	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	3.84	0.59	0.47	0.31	0.11	0	0.13	0.18	0.25	0.41	0.92	1.17	1.62
0	0	17.48	17.48	6.15	0.41	0.97	0	0	0.98	1.18	0.2	0	0	0	0	0	0	0
0.03	0.3	4.7	5.41	7.12	2.67	1	1.01	0.78	0.75	0.86	0.54	0.48	0.88	0.61	0.6	0.94	1	0.69
0.03	0.3	34.73	32.33	24.27	11.62	20.05	14.97	13.98	15.85	15	7.7	7.65	7.74	11.22	12.35	11.73	10.71	6.2
65.94	70.68	67.63	51.83	35.37	18.16	25.27	19.24	17.75	20.32	18.84	11.28	10.86	34.46	28.98	35.88	26.85	17.17	9.9

12.76	12.76	0	0	0	3.08	0.01	0	0	0	0	0	0	0	0	109.72	116.02	118.97	124.41
50.61	51.85	31.47	33.19	36.81	38.86	54.82	56.15	58.36	63.48	65.89	61.41	63.91	94.04	94.75	0	0	0	0
-0.44	1.07	-4.14	-4.66	-9.45	-29.69	-37.44	-39.7	-42.72	-47.33	-50.14	-52.01	-53.8	-58.05	-65.37	-74.14	-89.16	-100.67	-113.67
0	0	0	-4.93	-2.58	-2.5	-2.54	-2.02	-2.02	-1.91	-2.27	-2.05	-2.06	-2.42	-2.85	-2.77	-2.97	-3.39	-3.42
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
62.93	65.68	27.33	23.6	24.78	9.75	14.85	14.43	13.62	14.24	13.48	7.35	8.05	33.57	26.53	32.81	23.89	14.91	7.32
0	0	3.1	1.68	1.99	1.31	0.65	0.6	0.13	0.17	0.33	0.42	0.05	0.32	0.76	0.48	0.98	0.53	0.77
0.29	0.24	1.37	0.56	0.55	0.43	1.03	0.52	0.43	0.91	0.82	0.18	0	0.51	0.51	0.94	1.18	0.75	0.94
1.84	2.1	4.28	2.27	0.06	0.02	0.59	0.26	0.05	0.01	0.03	0.69	0.49	0	0.62	0.65	0.28	0.61	0.62
0.87	2.66	8.64	4.94	5.51	4.82	2.23	2.25	0.42	1.35	2.02	0	1.8	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	50	50	300	0	0	3
3	5	17.39	9.45	8.11	6.58	4.5	3.63	1.03	2.44	3.2	1.29	2.34	0.88	1.94	2.37	2.44	1.89	2.34
0	0	1.21	1.5	0	0	0	0	1.8	2.12	0.8	2.64	0.43	0	0	0.28	0.14	0.14	0.14
0	0	610	590	0	0	710	0	0	0	0	0	0	0	0	0	0	0	0
0	0	7.55	2.44	1.11	1.21	4.23	0.65	0.76	1.01	0.91	0	0.01	0.02	0.5	0.42	0.36	0.23	0.1
0	0	9.37	4.53	1.11	1.21	4.94	0.65	2.56	3.13	1.71	2.64	0.44	0.02	0.5	0.7	0.5	0.37	0.24
3	5	26.76	13.98	9.22	7.79	9.44	4.28	3.59	5.57	4.91	3.93	2.78	0.9	2.44	3.07	2.94	2.26	2.58
65.93	70.68	54.09	37.58	34	17.54	24.29	18.71	17.21	19.81	18.39	11.28	10.83	34.47	28.97	35.88	26.83	17.17	9.9

2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
0	1,000	-5,000	0	-4,000	-21,000	-7,000	-2,000	-3,000	-4,000	-2,000	-1,000	-1,000	-4,000	-7,000	-8,000	-15,000	-11,000
0	0	0	0	0	0	1,000	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	-3	4	0	0	0	0	0	0	0	0	0	0	0	0
0	0	-4	-10	-1	0	0	0	0	0	1	0	0	0	-3	-3	2	0
0	-3	2	0	6	13	1	1	1	1	0	0	0	0	1	0	4	3
0	0	1,000	1,000	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	-1	-8	-8	-1	-2	-5	0	-1	-2	0	-1	-1	-3	-8	-10	-7	-7
0	0	0	-2	-1	0	0	0	0	0	0	0	0	0	-4	-1	0	0
-65	0	57	2	-2	0	4	0	0	0	0	0	0	0	-9	3	0	0
-65	0	57	5	0	0	4	0	0	0	0	0	0	0	-5	4	0	0
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	3	-4	-1	1	0	0	0	0	0	0	0	0	-1	0	0	0	0
68	0	-33	0	1	3	0	0	1	2	1	0	3	29	0	14	4	0
65	3	-41	0	2	3	0	0	1	2	1	0	3	27	0	14	4	0
-4.00	-	-3.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	1	7	-6	-1	0	-1	0	0	0	0	0	1	23	-18	7	-4	-7
-0.1	-1.56	-8.57	-10.6	-3.19	-2.92	-5.03	-0.15	-1.75	-2.66	-0.28	-1.54	-2.13	-3.39	-13.15	-12.39	-8.2	-7.67
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

IGC Pharma 브루토마진	IGC Pharma 이익 마진	IGC Pharma EBIT-마진	IGC Pharma 이익 마진
2027e	54.5 %	-845 %	-442.29 %
2026e	54.5 %	-817.81 %	-582.31 %
2025e	54.5 %	-863.01 %	-694.79 %
2024	54.5 %	-654.13 %	-966.54 %
2023	48.35 %	-1,229.67 %	-1,264.84 %
2022	47.5 %	-2,670 %	-3,755 %
2021	12.22 %	-968.89 %	-978.89 %
2020	2.95 %	-168.8 %	-179.85 %
2019	2.54 %	-90.63 %	-80.08 %
2018	3.65 %	-81.74 %	-81.74 %
2017	37.93 %	-353.45 %	-322.41 %
2016	13.19 %	-40.66 %	-44.11 %
2015	7.55 %	-56.51 %	-60.03 %
2014	16.74 %	-110.57 %	-133.04 %
2013	19.05 %	-27.15 %	-28.02 %
2012	-14.76 %	-150.48 %	-184.52 %
2011	3.93 %	-194.35 %	-497.3 %
2010	12.46 %	-22.29 %	-26.76 %
2009	23.09 %	6.54 %	-1.47 %
2008	18.72 %	-0.91 %	-238.36 %
2007	54.5 %	0 %	0 %
2006	54.5 %	0 %	0 %

	브루토마진	EBIT-마진	이익 마진
2006	54.5 %	0 %	0 %
2007	54.5 %	0 %	0 %
2008	18.72 %	-0.91 %	-238.36 %
2009	23.09 %	6.54 %	-1.47 %
2010	12.46 %	-22.29 %	-26.76 %
2011	3.93 %	-194.35 %	-497.3 %
2012	-14.76 %	-150.48 %	-184.52 %
2013	19.05 %	-27.15 %	-28.02 %
2014	16.74 %	-110.57 %	-133.04 %
2015	7.55 %	-56.51 %	-60.03 %
2016	13.19 %	-40.66 %	-44.11 %
2017	37.93 %	-353.45 %	-322.41 %
2018	3.65 %	-81.74 %	-81.74 %
2019	2.54 %	-90.63 %	-80.08 %
2020	2.95 %	-168.8 %	-179.85 %
2021	12.22 %	-968.89 %	-978.89 %
2022	47.5 %	-2,670 %	-3,755 %
2023	48.35 %	-1,229.67 %	-1,264.84 %
2024	54.5 %	-654.13 %	-966.54 %
2025e	54.5 %	-863.01 %	-694.79 %
2026e	54.5 %	-817.81 %	-582.31 %
2027e	54.5 %	-845 %	-442.29 %

날짜	IGC Pharma 주당 매출	IGC Pharma EBIT 당 주식	IGC Pharma 주당 이익
2027e	0.02 undefined	0 undefined	-0.09 undefined
2026e	0.02 undefined	0 undefined	-0.1 undefined
2025e	0.02 undefined	0 undefined	-0.1 undefined
2024	0.02 undefined	-0.15 undefined	-0.22 undefined
2023	0.02 undefined	-0.21 undefined	-0.22 undefined
2022	0.01 undefined	-0.21 undefined	-0.3 undefined
2021	0.02 undefined	-0.21 undefined	-0.21 undefined
2020	0.1 undefined	-0.17 undefined	-0.19 undefined
2019	0.14 undefined	-0.13 undefined	-0.12 undefined
2018	0.08 undefined	-0.06 undefined	-0.06 undefined
2017	0.02 undefined	-0.08 undefined	-0.07 undefined
2016	0.39 undefined	-0.16 undefined	-0.17 undefined
2015	0.52 undefined	-0.29 undefined	-0.31 undefined
2014	0.28 undefined	-0.31 undefined	-0.37 undefined
2013	1.15 undefined	-0.31 undefined	-0.32 undefined
2012	1.44 undefined	-2.17 undefined	-2.66 undefined
2011	2.7 undefined	-5.24 undefined	-13.4 undefined
2010	15.57 undefined	-3.47 undefined	-4.17 undefined
2009	34.99 undefined	2.29 undefined	-0.51 undefined
2008	2.55 undefined	-0.02 undefined	-6.07 undefined
2007	0 undefined	0 undefined	1.09 undefined
2006	0 undefined	-0.38 undefined	-0.31 undefined

	주당 매출	EBIT 당 주식	주당 이익
2006	0 USD	-0.38 USD	-0.31 USD
2007	0 USD	0 USD	1.09 USD
2008	2.55 USD	-0.02 USD	-6.07 USD
2009	34.99 USD	2.29 USD	-0.51 USD
2010	15.57 USD	-3.47 USD	-4.17 USD
2011	2.7 USD	-5.24 USD	-13.4 USD
2012	1.44 USD	-2.17 USD	-2.66 USD
2013	1.15 USD	-0.31 USD	-0.32 USD
2014	0.28 USD	-0.31 USD	-0.37 USD
2015	0.52 USD	-0.29 USD	-0.31 USD
2016	0.39 USD	-0.16 USD	-0.17 USD
2017	0.02 USD	-0.08 USD	-0.07 USD
2018	0.08 USD	-0.06 USD	-0.06 USD
2019	0.14 USD	-0.13 USD	-0.12 USD
2020	0.1 USD	-0.17 USD	-0.19 USD
2021	0.02 USD	-0.21 USD	-0.21 USD
2022	0.01 USD	-0.21 USD	-0.3 USD
2023	0.02 USD	-0.21 USD	-0.22 USD
2024	0.02 USD	-0.15 USD	-0.22 USD
2025e	0.02 USD	0 USD	-0.1 USD
2026e	0.02 USD	0 USD	-0.1 USD
2027e	0.02 USD	0 USD	-0.09 USD

Segmente	2020	2019
Purchase and Resale of Physical Commodities	3.55 백만 USD	-
Wellness and Lifestyle	386,000 USD	-
Construction	101,000 USD	-
Tolling/White labeling service	25,000 USD	-
Rental Income	7,000 USD	-
	-	-
Legacy Infrastructure	3.66 백만 USD	5.09 백만 USD
Purchase and Resale of Physical Commodities	-	5.06 백만 USD
Plant and Cannabinoid	411,000 USD	25,000 USD
Rental Income	-	30,000 USD
Cannabinoid Products and Therapies	-	25,000 USD
Construction Contracts	-	-
Alternative Therapies	-	-
Legacy Business	-	-
Rental/Lease	-	-
Trading, electronic component	-	-
Trading	-	-
Construction	-	-
Legacy Infrastructure	-	5.09 백만 USD
Asia	-	70,000 USD
Plant and Cannabinoid	-	25,000 USD
Life Sciences	411,000 USD	-

날짜		Asia	COLOMBIA	HONG KONG	INDIA	North America	United States
2024	-	-	2,000 USD	-	164,000 USD	-	1.18 백만 USD
2022	329,000 USD	-	-	-	68,000 USD	-	-
2021	723,000 USD	-	-	-	175,000 USD	-	-
2020	-	-	-	3.55 백만 USD	108,000 USD	411,000 USD	-
2019	-	-	-	5.02 백만 USD	70,000 USD	25,000 USD	-
2018	-	395,444 USD	-	1.8 백만 USD	-	-	-
2017	213,093 USD	-	-	-	-	-	-
2016	6.25 백만 USD	-	-	-	-	-	-
2015	7.61 백만 USD	-	-	-	-	-	-
2014	2.2 백만 USD	-	-	-	-	-	-

	주식 수량
2006	1.4 백만 Aktien
2007	1.4 백만 Aktien
2008	860,000 Aktien
2009	1.01 백만 Aktien
2010	1.15 백만 Aktien
2011	1.51 백만 Aktien
2012	2.91 백만 Aktien
2013	6.97 백만 Aktien
2014	8.21 백만 Aktien
2015	14.76 백만 Aktien
2016	16.39 백만 Aktien
2017	25.66 백만 Aktien
2018	27.94 백만 Aktien
2019	35.39 백만 Aktien
2020	39.49 백만 Aktien
2021	41.96 백만 Aktien
2022	49.99 백만 Aktien
2023	52.58 백만 Aktien
2024	58.84 백만 Aktien
2025e	58.84 백만 Aktien
2026e	58.84 백만 Aktien
2027e	58.84 백만 Aktien

날짜	EPS-예상치	EPS-실제	보고 분기
	-0.03	-0.03 (-14.5 %)	2025 Q1
	-0.04	-0.4 (-890.1 %)	2024 Q4

%-지분	이름	주식	변경
2.96746 %	Prins (Richard K)	2,244,583	329,583
2.45196 %	Grimaldi (Claudia)	1,854,666	336,666
11.45062 %	Mukunda (Ram)	8,661,251	951,251
1.07196 %	Moran (James P)	810,834	220,834
0.94908 %	BlackRock Institutional Trust Company, N.A.	717,884	0
0.85294 %	The Vanguard Group, Inc.	645,166	0
0.42874 %	Geode Capital Management, L.L.C.	324,296	0
0.24340 %	State Street Global Advisors (US)	184,107	0
0.15430 %	Dearborn Partners L.L.C.	116,710	0
0.10163 %	Susquehanna International Group, LLP	76,872	22,321
0.09435 %	Northern Trust Investments, Inc.	71,364	0
0.09122 %	Bridgeway Capital Management, LLC	69,000	0
0.08659 %	Goldman Sachs & Company, Inc.	65,495	-1
0.08028 %	Virtu Americas LLC	60,723	-9,273
0.07993 %	Group One Trading, L.P.	60,459	-1,100
0.04848 %	Truist Bank	36,667	0
0.03888 %	Lierman (Terry L)	29,411	29,411
0.03083 %	Tower Research Capital LLC	23,317	1,982
0.00650 %	J.P. Morgan Securities LLC	4,917	4,917
0.00628 %	UBS Financial Services, Inc.	4,747	4,453
0.00397 %	Geneos Wealth Management Inc	3,000	0
0.00136 %	Osaic Holdings, Inc.	1,032	-1,082
0.00114 %	Morgan Stanley Smith Barney LLC	860	50
0.00049 %	Wells Fargo Bank, N.A.	373	74
0.00026 %	Caitlin John, LLC	200	200
0.00021 %	Fidelity Management & Research Company LLC	156	156
0.00011 %	DHJJ Financial Advisors, Ltd.	80	0
0.00003 %	GWM Advisors LLC	25	25
0.00001 %	TD Securities, Inc.	6	0
0 %	ExodusPoint Capital Management, LP	0	-13,049
0 %	Steward Partners Investment Advisory, LLC	0	-300
0 %	Simplex Trading, LLC	0	-1,000
0 %	Vident Investment Advisory, LLC	0	-121,563
0 %	HRT Financial LP	0	-18,148
0 %	Penserra Capital Management LLC	0	-120,486
0 %	Commonwealth Financial Network	0	-165,490
0 %	Cutler Group, LP	0	-796
0 %	Jane Street Capital, L.L.C.	0	-46,540
0 %	IQ EQ Fund Management (Ireland) Limited	0	-102,133
0 %	Two Sigma Investments, LP	0	-47,750
0 %	Millennium Management LLC	0	-14,276
0 %	Renaissance Technologies LLC	0	-86,902
0 %	Evermay Wealth Management, LLC	0	-30
0 %	Citadel Advisors LLC	0	-15,583
0 %	PNC Investments LLC	0	-200
0 %	Northwestern Mutual Capital, LLC	0	-2
0 %	Morgan Stanley & Co. LLC	0	-1
0 %	BofA Global Research (US)	0	-250
0 %	Game Plan Financial Advisors, LLC	0	-500

What values and corporate philosophy does IGC Pharma represent?

India Globalization Capital Inc (IGC) represents a strong commitment to innovation, growth, and value creation. With a focus on rapidly expanding markets, IGC leverages its expertise in developing and commercializing transformative products and solutions. The company's corporate philosophy centers around delivering exceptional shareholder value, fostering long-term partnerships, and adhering to the highest standards of corporate governance and ethics. By staying attuned to market trends and continuously enhancing its offerings, IGC stands as a leading player in sectors like cannabis-based therapies, specialty pharmaceuticals, and infrastructure. IGC's dedication to excellence and strategic approach underscores its mission to enhance the lives of millions through pioneering technologies and forward-thinking strategies.

In which countries and regions is IGC Pharma primarily present?

India Globalization Capital Inc (IGC) is primarily present in India and the United States. With its headquarters in Bethesda, Maryland, USA, IGC operates in various states across India and has a significant presence in its home country. The company focuses on developing and commercializing cannabis-based pharmaceutical and natural wellness products, as well as providing services to the telecommunications and infrastructure sectors. As a global player, IGC aims to leverage its expertise and strategic partnerships to expand its presence in other regions and countries, capitalizing on emerging market opportunities worldwide.

What significant milestones has the company IGC Pharma achieved?

India Globalization Capital Inc (IGC) has achieved several significant milestones over the years. One of the notable achievements is the company's entry into the medical cannabis market. By leveraging its expertise in plant-based therapies and advanced pharmaceutical technologies, IGC has developed a portfolio of cannabinoid-based combination therapies. This pioneering move has positioned the company uniquely in the industry, creating opportunities for substantial growth and market penetration. Moreover, IGC has successfully obtained multiple patents and intellectual property rights, solidifying its position as a leading player in the medical cannabis space. The company's dedication to innovation and strategic partnerships has enabled it to pave the way for novel treatments and carve a niche for itself in the market.

What is the history and background of the company IGC Pharma?

India Globalization Capital Inc. (IGC) is a prominent company founded in 2005. The company primarily operates in various sectors like infrastructure, plant extraction, and traditional Chinese medicine. With a vision to become a global leader, IGC focuses on informational technology-related products and services to fulfill evolving market needs. Throughout its history, IGC has successfully developed and commercialized a range of patented therapies, enhancing consumer healthcare experiences and quality of life. The company's commitment to innovation and diversified business portfolio have contributed to its substantial growth and recognition within the industry. IGC continues to strive towards providing cutting-edge solutions and driving positive advancements in various fields of operation.

Who are the main competitors of IGC Pharma in the market?

The main competitors of India Globalization Capital Inc in the market include companies such as Canopy Growth Corporation, Aurora Cannabis Inc, and Tilray Inc. These companies operate in the same industry and compete with India Globalization Capital Inc in areas such as cannabis-based pharmaceuticals, and alternative therapies and treatment solutions. India Globalization Capital Inc aims to differentiate itself through its proprietary intellectual property and innovative approaches in the market. However, it faces strong competition from these established players who also have a significant market presence and drive advancements in the industry.

In which industries is IGC Pharma primarily active?

India Globalization Capital Inc is primarily active in the industries of infrastructure, real estate, and pharmaceuticals.

What is the business model of IGC Pharma?

The business model of India Globalization Capital Inc (IGC) revolves around various sectors, including infrastructure, technologies, and pharmaceuticals. IGC primarily focuses on the development and commercialization of cannabis-based therapies to address various medical conditions. By leveraging their in-house research and expertise, IGC aims to create innovative cannabis formulations that can potentially improve patient outcomes and quality of life. Additionally, the company also engages in the leasing of heavy equipment, mining exploration, and reclamation of high-grade iron ore to generate sustainable revenue. Through their diversified business segments, IGC strives to deliver value to its shareholders and contribute to the evolving medical and infrastructure sectors.

IGC Pharma 2024의 P/E 비율은 얼마입니까?

IGC Pharma의 P/E 비율은 -1.74입니다.

IGC Pharma 2024의 KUV는 얼마입니까?

IGC Pharma의 P/S 비율은 16.86입니다.

IGC Pharma의 AlleAktien 품질 점수는 얼마인가요?

IGC Pharma에 대한 AlleAktien 품질 점수는 4/10입니다.

IGC Pharma 2024의 매출은 얼마인가요?

IGC Pharma 매출은 1.35 백만 USD입니다.

IGC Pharma 2024의 이익은 얼마인가요?

IGC Pharma 이익은 -13 백만 USD입니다.

IGC Pharma은 무엇을 하나요?

India Globalization Capital Inc. is a diversified company that operates in various industries including construction and infrastructure, heavy industry, agricultural and food production, as well as dietary supplements.

IGC Pharma 배당금은 얼마입니까?

IGC Pharma은(는) 연간 번의 배당을 통해 0 USD의 배당금을 지급합니다.

IGC Pharma이 얼마나 자주 배당을 지급하나요?

IGC Pharma의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

IGC Pharma ISIN이 무엇입니까?

IGC Pharma의 ISIN은 US45408X3089입니다.

IGC Pharma WKN은 무엇인가요?

IGC Pharma의 WKN은 A1T87A입니다.

IGC Pharma 티커는 무엇인가요?

IGC Pharma의 티커는 IGC입니다.

IGC Pharma이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 IGC Pharma은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 IGC Pharma은(는) 0 USD의 배당금을 지급할 것으로 예상됩니다.

IGC Pharma의 배당 수익률은 얼마입니까?

IGC Pharma의 현재 배당 수익률은 입니다.

IGC Pharma의 배당금은 언제 지급되나요?

IGC Pharma은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

IGC Pharma의 배당금은 얼마나 안전한가요?

IGC Pharma은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

IGC Pharma의 배당금은 얼마입니까?

향후 12개월 동안 0 USD의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

IGC Pharma이(가) 속해 있는 섹터는 어디인가요?

IGC Pharma은 '산업' 섹터에 속합니다.

Wann musste ich die Aktien von IGC Pharma kaufen, um die vorherige Dividende zu erhalten?

IGC Pharma의 마지막 배당금을 0 USD만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

IGC Pharma의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

IGC Pharma의 2023년도 배당금은 얼마였습니까?

2023년에 IGC Pharma는 0 USD를 배당금으로 지급했습니다.

IGC Pharma는 어떤 화폐로 배당금을 지급하나요?

IGC Pharma의 배당금은 USD에 지급됩니다.

증권거래소	IGC Pharma 티커
AMEX	IGC
프랑크푸르트	IGS1.F
뮌헨	IGS1.MU

IGC Pharma 티커	IGC Pharma FIGI
IGC:US	BBG000NSSLY8
IGC:UA	BBG000NSSM49
IGC:UC	BBG000NSSMB1
IGC:UN	BBG000NSSNB9
IGC:UP	BBG000NSSPG9
IGC:UB	BBG000NSSQ40
IGC:UT	BBG000NSSQQ6
IGC:UM	BBG000NSSR93
IGC:UX	BBG000NSSRV8
IGC:UD	BBG000NSTY33
IGC:UF	BBG000NSV0G0
IGC:VY	BBG000NSV114
IGC:VJ	BBG000NSV203
IGC:VK	BBG000NSV2L0
IGS1:GR	BBG000W6KD54
IGS1:GF	BBG000W6KDM5
IGS1:GS	BBG000W6KF22
IGS1:GM	BBG000W6KF77
IGS1:GB	BBG000W6KFG7
IGS1:TH	BBG000WHFQF6
IGC:VF	BBG00DJGFSY0
IGS1:GZ	BBG00K8GCVV5
IGC1EUR:X2	BBG00K8H57P1
IGC1EUR:XB	BBG00K8H57Q0
IGC1EUR:XH	BBG00K8H57T7
IGC1EUR:XF	BBG00K8H57W3
IGC1EUR:XE	BBG00K8H57Y1
IGC1EUR:XJ	BBG00K8H57Z0
IGC1EUR:XL	BBG00K8H5815
IGC1EUR:XG	BBG00K8H5833
IGC1EUR:XO	BBG00K8H5842
IGC1EUR:XS	BBG00K8H5888
IGC1EUR:XA	BBG00K8H5897
IGC1EUR:E1	BBG00K8H58B4
IGC1EUR:XT	BBG00K8H58D2
IGC1EUR:XW	BBG00K8H58F0
IGC1EUR:XU	BBG00K8H58G9
IGC1EUR:XV	BBG00K8H58H8
IGC1EUR:XM	BBG00K8H58J6
IGC1EUR:XQ	BBG00K8H58L3
IGC1EUR:XX	BBG00K8H58M2
IGC1EUR:XZ	BBG00K8H58N1
IGC1EUR:EU	BBG00K8H58R7
IGC:VG	BBG00X1NQTX7
IGC:VP	BBG00X1S5BY7
IGC1USD:XS	BBG00YQ95H22
IGC1USD:X2	BBG00YQ95H31
IGC1USD:XH	BBG00YQ95H59
IGC1USD:XF	BBG00YQ95H77
IGC1USD:XE	BBG00YQ95H95
IGC1USD:XJ	BBG00YQ95HB2
IGC1USD:XL	BBG00YQ95HC1
IGC1USD:XG	BBG00YQ95HD0
IGC1USD:XO	BBG00YQ95HF8
IGC1USD:XA	BBG00YQ95HK2
IGC1USD:E1	BBG00YQ95HL1
IGC1USD:XT	BBG00YQ95HM0
IGC1USD:XW	BBG00YQ95HN9
IGC1USD:XU	BBG00YQ95HP7
IGC1USD:XV	BBG00YQ95HR5
IGC1USD:XM	BBG00YQ95HS4
IGC1USD:XQ	BBG00YQ95HT3
IGC1USD:XX	BBG00YQ95HV0
IGC1USD:XZ	BBG00YQ95HW9
IGC1USD:X1	BBG00YQ95HY7
IGC1USD:EU	BBG00YQ95J19
IGS1:LA	BBG018H92SN4
IGS1:LU	BBG018J2QTJ4

2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025e	2026e	2027e
0	0	2	35	17	4	4	8	2	7	6	0	2	5	4	0	0	0	1	1	1	1
-	-	-	1,650.00	-51.43	-76.47	-	100.00	-75.00	250.00	-14.29	-	-	150.00	-20.00	-	-	-	-	-	-	-
-	-	-	22.86	11.76	-	-	12.50	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0	0	0	8	2	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	2	-3	-7	-6	-2	-2	-4	-2	-2	-1	-4	-6	-8	-10	-11	-8	-9	-10	-12
-	-	-	5.71	-17.65	-175.00	-150.00	-25.00	-100.00	-57.14	-33.33	-	-50.00	-80.00	-150.00	-	-	-	-800.00	-900.00	-1,000.00	-1,200.00
0	1,000	-5,000	0	-4,000	-20,000	-7,000	-2,000	-3,000	-4,000	-2,000	-1,000	-1,000	-4,000	-7,000	-8,000	-15,000	-11,000	-13,000	-7,000	-7,000	-6,000
-	-	-600.00	-	-	400.00	-65.00	-71.43	50.00	33.33	-50.00	-50.00	-	300.00	75.00	14.29	87.50	-26.67	18.18	-46.15	-	-14.29
1.4	1.4	0.86	1.01	1.15	1.51	2.91	6.97	8.21	14.76	16.39	25.66	27.94	35.39	39.49	41.96	49.99	52.58	58.84	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

한 눈에 저평가된 주식을 인식하세요 fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

IGC Pharma 주식 주식과 주식 분석 IGC Pharma ariva, IGC Pharma onvista, IGC Pharma finanzen.net, IGC Pharma aktienfinder, IGC Pharma marketscreener, IGC Pharma marketwatch, IGC Pharma bloomberg, IGC Pharma handelsblatt, IGC Pharma wiwo, IGC Pharma forum

가격

가격

티커IGC

ISINUS45408X3089

WKNA1T87A

IGC Pharma 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

IGC Pharma 주가 이력

IGC Pharma 주식 매출, EBIT, 이익 US45408X3089 · A1T87A

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

IGC Pharma 매출, 이익 및 EBIT 역사

IGC Pharma 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

IGC Pharma 주식 마진 US45408X3089 · A1T87A

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

IGC Pharma 마진 역사

IGC Pharma 주식 매출, EBIT, 주당 순이익 US45408X3089 · A1T87A

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

IGC Pharma 매출, 이익 및 EBIT 주당 역사

IGC Pharma 주식 및 주식 분석

IGC Pharma 매출 세분화 US45408X3089 · A1T87A

세그먼트별 매출

세그먼트별 매출 개요

해석 및 사용

투자 전략

IGC Pharma 매출 세분화

IGC Pharma 지역별 매출 US45408X3089 · A1T87A

세그먼트별 매출

지역별 매출 개요

해석 및 사용법

투자 전략

IGC Pharma 매출 세분화

IGC Pharma Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

IGC Pharma 역사적인 P/E, EBIT 및 P/S에 따른 평가

IGC Pharma 주식 수량 US45408X3089 · A1T87A

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

한 눈에 저평가된 주식을 인식하세요
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

IGC Pharma 주식
주식과 주식 분석 IGC Pharma ariva, IGC Pharma onvista, IGC Pharma finanzen.net, IGC Pharma aktienfinder, IGC Pharma marketscreener, IGC Pharma marketwatch, IGC Pharma bloomberg, IGC Pharma handelsblatt, IGC Pharma wiwo, IGC Pharma forum

티커
IGC

ISIN
US45408X3089

WKN
A1T87A